ISIN | CH0586377134 |
---|---|
Valor Number | 58637713 |
Bloomberg Global ID | |
Fund Name | acrevis spektrum Fund Aktien Schweiz VtN |
Fund Provider |
acrevis Bank AG
St. Gallen, Switzerland Phone: +41 58 122 75 55 E-Mail: info@acrevis.ch Web: www.acrevis.ch |
Fund Provider | acrevis Bank AG |
Representative in Switzerland | |
Distributor(s) |
acrevis Bank AG St. Gallen |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Das Anlageziel besteht hauptsächlich darin, einen langfristigen Kapitalzuwachs verbunden mit angemessenen Erträgen zu erzielen und die Performance des im Anhang erwähnten Referenzindex (nachfolgend "Referenzindex") durch aktives Management zu übertreffen, wobei von Anlagen im Referenzindex abgewichen werden kann. |
Peculiarities |
Current Price * | 122.50 CHF | 17.09.2025 |
---|---|---|
Previous Price * | 122.50 CHF | 16.09.2025 |
52 Week High * | 128.76 CHF | 13.02.2025 |
52 Week Low * | 106.26 CHF | 09.04.2025 |
NAV * | 122.50 CHF | 17.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 160,138,116 | |
Unit/Share Assets *** | 159,910,669 | |
Trading Information SIX |
YTD Performance | +6.78% |
31.12.2024 - 17.09.2025
31.12.2024 17.09.2025 |
---|---|---|
1 month | +0.36% |
18.08.2025 - 17.09.2025
18.08.2025 17.09.2025 |
3 months | +0.65% |
17.06.2025 - 17.09.2025
17.06.2025 17.09.2025 |
6 months | -3.51% |
17.03.2025 - 17.09.2025
17.03.2025 17.09.2025 |
1 year | +2.15% |
17.09.2024 - 17.09.2025
17.09.2024 17.09.2025 |
2 years | +16.51% |
18.09.2023 - 17.09.2025
18.09.2023 17.09.2025 |
3 years | +28.55% |
19.09.2022 - 17.09.2025
19.09.2022 17.09.2025 |
5 years | +22.50% |
25.01.2021 - 17.09.2025
25.01.2021 17.09.2025 |
Equity Participation Rate in % | 99.53 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 12.30% | |
---|---|---|
Nestle SA | 11.62% | |
Roche Holding AG | 11.16% | |
Zurich Insurance Group AG | 5.69% | |
Lonza Group Ltd | 5.54% | |
ABB Ltd | 5.48% | |
Swissquote Group Holding SA | 4.66% | |
Swiss Life Holding AG | 4.60% | |
Compagnie Financiere Richemont SA Class A | 4.55% | |
Logitech International SA | 3.94% | |
Last data update | 31.08.2025 |
TER | 0.00% |
---|---|
TER date | 31.10.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |